Skip to search formSkip to main contentSkip to account menu

Anti-ErbB3 Monoclonal Antibody KTN3379

Known as: KTN3379 
A monoclonal antibody directed against the human epidermal growth factor receptor ErbB3 (Her3) with potential antineoplastic activity. Anti-ErbB3… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
BYL719 is a PI3K inhibitor that has demonstrated efficacy in the treatment of head and neck squamous cell carcinoma. BYL719… 
2017
2017
Head and neck squamous cell carcinoma (HNSCC) accounts for 3–5% of all tumor types and remains an unmet medical need with only… 
2016
2016
Purpose: Human papillomavirus (HPV) 16 plays an etiologic role in a growing subset of head and neck squamous cell carcinomas… 
2016
2016
HER3/ERBB3 is a kinase-deficient member of the EGFR family receptor tyrosine kinases (RTK) that is broadly expressed and… 
2016
2016
2501Background: KTN3379 is a fully human anti-ErbB3 antibody with YTE half-life extension engineering that uniquely binds domain… 
2016
2016
We describe the management of subretinal fluid and macular oedema due to colorectal cancer metastasis to the choroid using… 
2016
2016
ErbB3, the kinase-dead member of the EGFR/ErbB family, has been implicated as an oncogenic driver in a number of solid tumor… 
2015
2015
Significance Many cancers are driven by aberrant activation of members of the EGF receptor (EGFR) family including ErbB2 (HER2… 
2015
2015
2598 Background: KTN3379 is a human monoclonal antibody against a unique epitope of human epidermal growth factor receptor-3… 
Review
2015
Review
2015
Aberrant regulation of the HER family of receptor tyrosine kinases (RTK) has proven to be a driver for promoting tumor growth and…